A case of sintilimab-induced SJS/TEN:Dermatologic adverse reactions associated with programmed cell death protein-1 inhibitors.

Huang, Ying; Zhu, Lin; Ma, Xiaoying; Hong, Yiyong; Su, Xiangyang; Lai, Wei; Gong, Zijian

Huang, Ying; Zhu, Lin; Ma, Xiaoying; Hong, Yiyong; Su, Xiangyang; Lai, Wei; Gong, Zijian.

Afiliação

Huang Y; Department of Dermatology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Zhu L; Department of Dermatology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Ma X; Department of Oncology, Guangzhou Mordern Hospital, Guangzhou, China.
Hong Y; Department of Dermatology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Su X; Department of Dermatology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Lai W; Department of Dermatology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Gong Z; Department of Dermatology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

Dermatol Ther ; 35(9): e15663, 2022 09.

Article em En | MEDLINE | ID: mdl-35739068

Assuntos

Inibidores de Checkpoint Imunológico; Síndrome de Stevens-Johnson; Anticorpos Monoclonais Humanizados/efeitos adversos; Proteínas Reguladoras de Apoptose; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndrome de Stevens-Johnson / Inibidores de Checkpoint Imunológico Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Dermatol Ther Assunto da revista: DERMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google